Valeant Pharmaceuticals International Inc. on Monday said it expects to report its first-quarter earnings earlier than its deadline to avoid defaulting on its debt agreements.
The Canadian drug company said it would file its latest 10-Q by June 10, ahead of the July 31 deadline stipulated in the company's amended credit agreement. Valeant also said it expects to file quarterly filings for the current quarter, which...
More